Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin CVitamin C (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Effects of Vitamin C Supplements on Clinical Outcomes and Hospitalization Duration for Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis

Qin et al., Nutrition Reviews, doi:10.1093/nutrit/nuae154, PROSPERO CRD42023491517
Nov 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 36% Improvement Relative Risk Severe case 41% Vitamin C for COVID-19  Qin et al.  META ANALYSIS c19early.org Favorsvitamin C Favorscontrol 0 0.5 1 1.5 2+
Vitamin C for COVID-19
6th treatment shown to reduce risk in September 2020, now with p = 0.00000002 from 73 studies, recognized in 12 countries.
Lower risk for mortality, ICU, hospitalization, and recovery.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Meta analysis of 22 studies with 6,831 patients showing significantly lower COVID-19 mortality and severity with vitamin C treatment.
7 meta analyses show significant improvements with vitamin C for mortality1-5, progression6, severity1,5, and cases7.
Currently there are 73 vitamin C for COVID-19 studies, showing 20% lower mortality [10‑28%], 9% lower ventilation [-12‑27%], 14% lower ICU admission [2‑24%], 19% lower hospitalization [7‑30%], and 3% fewer cases [-16‑19%].
risk of death, 36.0% lower, OR 0.64, p < 0.001, RR approximated with OR.
risk of severe case, 41.0% lower, OR 0.59, p < 0.001, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Qin et al., 11 Nov 2024, peer-reviewed, 8 authors, study period January 2020 - December 2023, trial PROSPERO CRD42023491517.
This PaperVitamin CAll
{ 'indexed': { 'date-parts': [[2024, 11, 12]], 'date-time': '2024-11-12T05:14:27Z', 'timestamp': 1731388467810, 'version': '3.28.0'}, 'reference-count': 62, 'publisher': 'Oxford University Press (OUP)', 'license': [ { 'start': { 'date-parts': [[2024, 11, 11]], 'date-time': '2024-11-11T00:00:00Z', 'timestamp': 1731283200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://academic.oup.com/pages/standard-publication-reuse-rights'}], 'funder': [ { 'DOI': '10.13039/501100018542', 'name': 'Natural Science Foundation of Sichuan Province', 'doi-asserted-by': 'publisher', 'award': ['2022NSFSC1587'], 'id': [{'id': '10.13039/501100018542', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:title>Abstract</jats:title>\n' ' <jats:sec>\n' ' <jats:title>Context</jats:title>\n' ' <jats:p>Vitamin\u2009C has been used as an essential antioxidant to reduce ' 'the inflammatory response associated with pneumonia and acute respiratory distress syndrome ' 'in patients with the 2019 coronavirus disease (COVID-19), but its effect on clinical outcomes ' 'remains controversial and inconclusive.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Objective</jats:title>\n' ' <jats:p>The purpose of this study was to conduct a meta-analysis and ' 'systematic review to assess the effects of vitamin\u2009C supplementation on the severity of ' 'COVID-19 in hospitalized patients.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Data Sources</jats:title>\n' ' <jats:p>Web of Science, Embase, Cochrane Library, PubMed, CNKI, CSTJ, Wan ' 'fang, and CBM databases were searched for publications between January 2020 and December 2023 ' 'that met the inclusion criteria.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Data Extraction</jats:title>\n' ' <jats:p>The meta-analyses of outcomes in more than one study were performed ' 'using Review Manager software. Heterogeneity was evaluated using the I2 statistic. A ' 'randomized controlled trial, cohort studies, and retrospective studies in which vitamin\u2009' 'C supplementation was supplemented as monotherapy or in combination, compared with placebo, ' 'no treatment, or other standard treatment without vitamin\u2009C were included.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Data Analysis</jats:title>\n' ' <jats:p>After screening, 22 studies, with a total of 6831 patients, were ' 'selected for assessment. Odds ratios (ORs) with 95% CIs were calculated using fixed- and ' 'random-effects models. The meta-analysis showed significant effects of vitamin\u2009C on ' 'alleviating clinical outcomes in patients with COVID-19 (OR\u2009=\u20090.76, 95% CI\u2009' '=\u20090.65–0.89, P\u2009=\u2009.0007) but no shortening of the length of hospitalization ' '(OR\u2009=\u20091.16, 95% CI\u2009=\u2009−0.13–2.44, P\u2009=\u2009.08) compared with the ' 'control group. Notably, vitamin\u2009C supplements significantly reduced the mortality risk ' '(OR\u2009=\u20090.64, 95% CI\u2009=\u20090.51–0.80, P\u2009=\u2009.0001) and the incidence of ' 'severity (OR\u2009=\u20090.59, 95% CI\u2009=\u20090.43–0.80, P\u2009=\u2009.0006) in COVID-19 ' 'patients.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Conclusion</jats:title>\n' ' <jats:p>The findings suggest that vitamin\u2009C supplements may have a ' 'beneficial effect on clinical outcomes, as well as reducing severity and mortality in ' 'COVID-19 patients, but more clinical randomized controlled trials are needed to evaluate the ' 'role of vitamin\u2009C in treating COVID-19.</jats:p>\n' ' </jats:sec>\n' ' <jats:sec>\n' ' <jats:title>Systematic Review Registration</jats:title>\n' ' <jats:p>PROSPERO registration no. CRD42023491517.</jats:p>\n' ' </jats:sec>', 'DOI': '10.1093/nutrit/nuae154', 'type': 'journal-article', 'created': { 'date-parts': [[2024, 11, 11]], 'date-time': '2024-11-11T16:10:57Z', 'timestamp': 1731341457000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Effects of Vitamin C Supplements on Clinical Outcomes and Hospitalization Duration for Patients ' 'with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis', 'prefix': '10.1093', 'author': [ { 'given': 'Maorong', 'family': 'Qin', 'sequence': 'first', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}]}, { 'given': 'Kun', 'family': 'Xu', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}]}, { 'given': 'Zhuo', 'family': 'Chen', 'sequence': 'additional', 'affiliation': [ { 'name': 'Xinqiao Stomatological Hospital Co., Ltd , Chengdu 610093,', 'place': ['China']}]}, { 'given': 'Xiaojie', 'family': 'Wen', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}]}, { 'given': 'Yifu', 'family': 'Tang', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}]}, { 'given': 'Yangyu', 'family': 'Gao', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}]}, { 'given': 'Hao', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Nuclear Medicine, Affiliated Hospital of North ' 'Sichuan Medical College , Nanchong 637199,', 'place': ['China']}]}, { 'ORCID': 'http://orcid.org/0000-0002-1860-4764', 'authenticated-orcid': False, 'given': 'Xingming', 'family': 'Ma', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Health Management, Xihua University , Chengdu 610039,', 'place': ['China']}, { 'name': 'Health Promotion Center, Xihua University , Chengdu 610039,', 'place': ['China']}]}], 'member': '286', 'published-online': {'date-parts': [[2024, 11, 11]]}, 'reference': [ { 'key': '2024111116104667700_nuae154-B1', 'doi-asserted-by': 'crossref', 'first-page': 'e0246824', 'DOI': '10.1371/journal.pone.0246824', 'article-title': 'The impact of COVID-19 pandemic on physical and mental health of ' 'Asians: a study of seven middle-income countries in Asia', 'volume': '16', 'author': 'Wang', 'year': '2021', 'journal-title': 'PLoS One'}, { 'key': '2024111116104667700_nuae154-B2', 'doi-asserted-by': 'crossref', 'first-page': '2075', 'DOI': '10.1039/D0LC00373E', 'article-title': 'Clinical decision support tool and rapid point-of-care platform for ' 'determining disease severity in patients with COVID-19', 'volume': '20', 'author': 'McRae', 'year': '2020', 'journal-title': 'Lab Chip'}, { 'key': '2024111116104667700_nuae154-B3', 'doi-asserted-by': 'crossref', 'first-page': '38', 'DOI': '10.1038/s41581-022-00642-4', 'article-title': 'Therapeutic advances in COVID-19', 'volume': '19', 'author': 'Murakami', 'year': '2023', 'journal-title': 'Nat Rev Nephrol'}, { 'key': '2024111116104667700_nuae154-B4', 'doi-asserted-by': 'crossref', 'first-page': '1125246', 'DOI': '10.3389/fimmu.2023.1125246', 'article-title': 'The development of COVID-19 treatment', 'volume': '14', 'author': 'Yuan', 'year': '2023', 'journal-title': 'Front Immunol'}, { 'key': '2024111116104667700_nuae154-B5', 'doi-asserted-by': 'crossref', 'first-page': '4217', 'DOI': '10.3390/nu14194217', 'article-title': 'Vitamin C supplementation for the treatment of COVID-19: a systematic ' 'review and meta-analysis', 'volume': '14', 'author': 'Olczak-Pruc', 'year': '2022', 'journal-title': 'Nutrients'}, { 'key': '2024111116104667700_nuae154-B6', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1111/j.1742-4658.2006.05607.x', 'article-title': 'Vitamin C. biosynthesis, recycling and degradation in mammals', 'volume': '274', 'author': 'Linster', 'year': '2007', 'journal-title': 'FEBS J'}, { 'key': '2024111116104667700_nuae154-B7', 'doi-asserted-by': 'crossref', 'first-page': '4449', 'DOI': '10.1007/s11010-021-04240-z', 'article-title': 'Vitamin C for sepsis intervention: from redox biochemistry to clinical ' 'medicine', 'volume': '476', 'author': 'Li', 'year': '2021', 'journal-title': 'Mol Cell Biochem'}, { 'key': '2024111116104667700_nuae154-B8', 'doi-asserted-by': 'crossref', 'first-page': '78', 'DOI': '10.1016/j.freeradbiomed.2008.09.028', 'article-title': 'Gene expression profiling reveals new protective roles for vitamin C in ' 'human skin cells', 'volume': '46', 'author': 'Duarte', 'year': '2009', 'journal-title': 'Free Radic Biol Med'}, { 'key': '2024111116104667700_nuae154-B9', 'doi-asserted-by': 'crossref', 'first-page': '2884', 'DOI': '10.3390/foods11182884', 'article-title': 'Are nutraceuticals effective in COVID-19 and post-COVID prevention and ' 'treatment?', 'volume': '11', 'author': 'Catalano', 'year': '2022', 'journal-title': 'Foods'}, { 'key': '2024111116104667700_nuae154-B10', 'doi-asserted-by': 'crossref', 'first-page': '1147', 'DOI': '10.1042/BST20180169', 'article-title': 'Vitamin C and immune cell function in inflammation and cancer', 'volume': '46', 'author': 'Ang', 'year': '2018', 'journal-title': 'Biochem Soc Trans'}, { 'key': '2024111116104667700_nuae154-B11', 'doi-asserted-by': 'crossref', 'first-page': '574029', 'DOI': '10.3389/fimmu.2020.574029', 'article-title': 'The long history of vitamin C: from prevention of the common cold to ' 'potential aid in the treatment of COVID-19', 'volume': '11', 'author': 'Cerullo', 'year': '2020', 'journal-title': 'Front Immunol'}, { 'key': '2024111116104667700_nuae154-B12', 'doi-asserted-by': 'crossref', 'first-page': '1236', 'DOI': '10.1189/jlb.0806541', 'article-title': 'Ascorbate deficiency results in impaired neutrophil apoptosis and ' 'clearance and is associated with up-regulation of hypoxia-inducible ' 'factor 1α', 'volume': '81', 'author': 'Vissers', 'year': '2007', 'journal-title': 'J Leukoc Biol'}, { 'key': '2024111116104667700_nuae154-B13', 'doi-asserted-by': 'crossref', 'first-page': '1211', 'DOI': '10.3390/nu9111211', 'article-title': 'Vitamin C and immune function', 'volume': '9', 'author': 'Carr', 'year': '2017', 'journal-title': 'Nutrients'}, { 'key': '2024111116104667700_nuae154-B14', 'doi-asserted-by': 'crossref', 'first-page': '2102', 'DOI': '10.3390/nu11092102', 'article-title': 'Vitamin C and neutrophil function: findings from randomized controlled ' 'trials', 'volume': '11', 'author': 'Liugan', 'year': '2019', 'journal-title': 'Nutrients'}, { 'key': '2024111116104667700_nuae154-B15', 'doi-asserted-by': 'crossref', 'first-page': '2054', 'DOI': '10.1089/ars.2012.4988', 'article-title': 'Vitamin C promotes maturation of T-cells', 'volume': '19', 'author': 'Manning', 'year': '2013', 'journal-title': 'Antioxid Redox Signal'}, { 'issue': 'suppl', 'key': '2024111116104667700_nuae154-B16', 'first-page': 'S6, S8', 'article-title': 'Vitamin C: a wound healing perspective', 'author': 'Moores', 'year': '2013', 'journal-title': 'Br J Community Nurs'}, { 'key': '2024111116104667700_nuae154-B17', 'doi-asserted-by': 'crossref', 'first-page': '2678', 'DOI': '10.1073/pnas.68.11.2678', 'article-title': 'The significance of the evidence about ascorbic acid and the common ' 'cold', 'volume': '68', 'author': 'Pauling', 'year': '1971', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'key': '2024111116104667700_nuae154-B18', 'doi-asserted-by': 'crossref', 'first-page': '1073', 'DOI': '10.1001/jama.1975.03240220051025', 'article-title': 'Ascorbic acid and the common cold. Evaluation of its efficacy and ' 'toxicity', 'volume': '231', 'author': 'Dykes', 'year': '1975', 'journal-title': 'JAMA'}, { 'key': '2024111116104667700_nuae154-B19', 'first-page': 'CD000980', 'article-title': 'Vitamin C for preventing and treating the common cold', 'volume': '2013', 'author': 'Hemilä', 'year': '2013', 'journal-title': 'Cochrane Database Syst Rev'}, { 'key': '2024111116104667700_nuae154-B20', 'doi-asserted-by': 'crossref', 'first-page': '94', 'DOI': '10.4103/2279-042X.179569', 'article-title': 'Effect of high-dose ascorbic acid on vasopressor’s requirement in ' 'septic shock', 'volume': '5', 'author': 'Zabet', 'year': '2016', 'journal-title': 'J Res Pharm Pract'}, { 'key': '2024111116104667700_nuae154-B21', 'doi-asserted-by': 'crossref', 'first-page': '1261', 'DOI': '10.1001/jama.2019.11825', 'article-title': 'Effect of vitamin C infusion on organ failure and biomarkers of ' 'inflammation and vascular injury in patients with sepsis and severe ' 'acute respiratory failure: the CITRIS-ALI randomized clinical trial', 'volume': '322', 'author': 'Fowler', 'year': '2019', 'journal-title': 'JAMA'}, { 'key': '2024111116104667700_nuae154-B22', 'doi-asserted-by': 'crossref', 'first-page': '242', 'DOI': '10.1016/j.ajem.2021.08.012', 'article-title': 'Efficacy of intravenous vitamin C intervention for septic patients: a ' 'systematic review and meta-analysis based on randomized controlled ' 'trials', 'volume': '50', 'author': 'Li', 'year': '2021', 'journal-title': 'Am J Emerg Med'}, { 'key': '2024111116104667700_nuae154-B23', 'doi-asserted-by': 'crossref', 'first-page': '32', 'DOI': '10.1186/1479-5876-12-32', 'article-title': 'Phase I safety trial of intravenous ascorbic acid in patients with ' 'severe sepsis', 'volume': '12', 'author': 'Fowler', 'year': '2014', 'journal-title': 'J Transl Med'}, { 'key': '2024111116104667700_nuae154-B24', 'doi-asserted-by': 'crossref', 'first-page': '172889', 'DOI': '10.1016/j.ejphar.2019.172889', 'article-title': 'Efficacy of vitamin C in patients with sepsis: an updated meta-analysis', 'volume': '868', 'author': 'Wei', 'year': '2020', 'journal-title': 'Eur J Pharmacol'}, { 'key': '2024111116104667700_nuae154-B25', 'doi-asserted-by': 'crossref', 'first-page': 'e33989', 'DOI': '10.2196/33989', 'article-title': 'Administration of parenteral vitamin C in patients with severe ' 'infection: protocol for a systematic review and meta-analysis', 'volume': '11', 'author': 'Agarwal', 'year': '2022', 'journal-title': 'JMIR Res Protoc'}, { 'key': '2024111116104667700_nuae154-B26', 'doi-asserted-by': 'crossref', 'first-page': '2550', 'DOI': '10.3390/nu12092550', 'article-title': 'Could vitamins help in the fight against COVID-19?', 'volume': '12', 'author': 'Jovic', 'year': '2020', 'journal-title': 'Nutrients'}, { 'key': '2024111116104667700_nuae154-B27', 'doi-asserted-by': 'crossref', 'first-page': '5682', 'DOI': '10.3748/wjg.v27.i34.5682', 'article-title': 'Liver disease and COVID-19: the link with oxidative stress, ' 'antioxidants and nutrition', 'volume': '27', 'author': 'Ristic-Medic', 'year': '2021', 'journal-title': 'World J Gastroenterol'}, {'key': '2024111116104667700_nuae154-B28', 'author': 'Higgins'}, { 'key': '2024111116104667700_nuae154-B29', 'doi-asserted-by': 'crossref', 'first-page': '924', 'DOI': '10.1136/bmj.39489.470347.AD', 'article-title': 'GRADE: an emerging consensus on rating quality of evidence and strength ' 'of recommendations', 'volume': '336', 'author': 'Guyatt', 'year': '2008', 'journal-title': 'BMJ'}, { 'key': '2024111116104667700_nuae154-B30', 'doi-asserted-by': 'crossref', 'first-page': '817829', 'DOI': '10.3389/fimmu.2022.817829', 'article-title': 'Convalescent plasma treatment in patients with COVID-19: a systematic ' 'review and meta-analysis', 'volume': '13', 'author': 'Jorda', 'year': '2022', 'journal-title': 'Front Immunol'}, { 'key': '2024111116104667700_nuae154-B31', 'doi-asserted-by': 'crossref', 'first-page': 'e210369', 'DOI': '10.1001/jamanetworkopen.2021.0369', 'article-title': 'Effect of high-dose zinc and ascorbic acid supplementation vs usual ' 'care on symptom length and reduction among ambulatory patients with ' 'SARS-CoV-2 infection: the COVID A to Z randomized clinical trial', 'volume': '4', 'author': 'Thomas', 'year': '2021', 'journal-title': 'JAMA Netw Open'}, { 'key': '2024111116104667700_nuae154-B32', 'doi-asserted-by': 'crossref', 'first-page': '20', 'DOI': '10.1186/s40001-021-00490-1', 'article-title': 'Safety and effectiveness of high-dose vitamin C in patients with ' 'COVID-19: a randomized open-label clinical trial', 'volume': '26', 'author': 'JamaliMoghadamSiahkali', 'year': '2021', 'journal-title': 'Eur J Med Res'}, { 'key': '2024111116104667700_nuae154-B33', 'doi-asserted-by': 'crossref', 'first-page': '695', 'DOI': '10.3122/jabfm.2022.04.210529', 'article-title': 'A pilot of a randomized control trial of melatonin and vitamin C for ' 'mild-to-moderate COVID-19', 'volume': '35', 'author': 'Fogleman', 'year': '2022', 'journal-title': 'J Am Board Fam Med'}, { 'key': '2024111116104667700_nuae154-B34', 'first-page': '460', 'article-title': 'An investigation into the effects of intravenous vitamin C on pulmonary ' 'CT findings and clinical outcomes of patients with COVID-19 pneumonia a ' 'randomized clinical trial', 'volume': '19', 'author': 'Tehrani', 'year': '2022', 'journal-title': 'Urol J'}, { 'key': '2024111116104667700_nuae154-B35', 'doi-asserted-by': 'crossref', 'first-page': '1759', 'DOI': '10.1007/s11739-022-02954-6', 'article-title': 'High-dose intravenous vitamin C decreases rates of mechanical ' 'ventilation and cardiac arrest in severe COVID-19', 'volume': '17', 'author': 'Hess', 'year': '2022', 'journal-title': 'Intern Emerg Med'}, { 'key': '2024111116104667700_nuae154-B36', 'doi-asserted-by': 'crossref', 'first-page': '64', 'DOI': '10.4103/jrpp.jrpp_30_22', 'article-title': 'High-dose intravenous vitamin C in early stages of severe acute ' 'respiratory syndrome coronavirus 2 infection: a double-blind, ' 'randomized, controlled clinical trial', 'volume': '11', 'author': 'Labbani-Motlagh', 'year': '2022', 'journal-title': 'J Res Pharm Pract'}, { 'key': '2024111116104667700_nuae154-B37', 'doi-asserted-by': 'crossref', 'first-page': '5', 'DOI': '10.1186/s13613-020-00792-3', 'article-title': 'Pilot trial of high-dose vitamin C in critically ill COVID-19 patients', 'volume': '11', 'author': 'Zhang', 'year': '2021', 'journal-title': 'Ann Intensive Care'}, { 'key': '2024111116104667700_nuae154-B38', 'doi-asserted-by': 'crossref', 'first-page': '7020', 'DOI': '10.18632/aging.202557', 'article-title': 'The efficiency and safety of high-dose vitamin C in patients with ' 'COVID-19: a retrospective cohort study', 'volume': '13', 'author': 'Gao', 'year': '2021', 'journal-title': 'Aging (Albany NY)'}, { 'key': '2024111116104667700_nuae154-B39', 'doi-asserted-by': 'crossref', 'first-page': '60', 'DOI': '10.1177/08971900211015052', 'article-title': 'Use of intravenous vitamin C in critically ill patients with COVID-19 ' 'infection', 'volume': '36', 'author': 'Li', 'year': '2023', 'journal-title': 'J Pharm Pract'}, { 'key': '2024111116104667700_nuae154-B40', 'doi-asserted-by': 'crossref', 'first-page': '425', 'DOI': '10.18621/eurj.938778', 'article-title': 'The use of vitamin C in the intensive care unit during the COVID-19 ' 'pandemic', 'volume': '7', 'author': 'Ozgunay', 'year': '2021', 'journal-title': 'European Res J'}, { 'key': '2024111116104667700_nuae154-B41', 'doi-asserted-by': 'crossref', 'first-page': '1403', 'DOI': '10.1515/med-2021-0361', 'article-title': 'No significant benefit of moderate-dose vitamin C on severe COVID-19 ' 'cases', 'volume': '16', 'author': 'Zheng', 'year': '2021', 'journal-title': 'Open Med (Wars)'}, { 'key': '2024111116104667700_nuae154-B42', 'doi-asserted-by': 'crossref', 'first-page': '17648', 'DOI': '10.1038/s41598-021-96703-y', 'article-title': 'Ascorbic acid as an adjunctive therapy in critically ill patients with ' 'COVID-19: a propensity score matched study', 'volume': '11', 'author': 'Al Sulaiman', 'year': '2021', 'journal-title': 'Sci Rep'}, { 'key': '2024111116104667700_nuae154-B43', 'first-page': '356', 'article-title': 'Effect of high-dose intravenous vitamin C on prognosis in patients with ' 'SARS-CoV-2 pneumonia', 'volume': '158', 'author': 'Suna', 'year': '2022', 'journal-title': 'Med Clin (Engl Ed)'}, { 'key': '2024111116104667700_nuae154-B44', 'doi-asserted-by': 'crossref', 'first-page': '111405', 'DOI': '10.1016/j.nut.2021.111405', 'article-title': 'High-dose intravenous vitamin C attenuates hyperinflammation in severe ' 'coronavirus disease 2019', 'volume': '91–92', 'author': 'Xia', 'year': '2021', 'journal-title': 'Nutrition'}, { 'key': '2024111116104667700_nuae154-B45', 'doi-asserted-by': 'crossref', 'first-page': '1542', 'DOI': '10.3855/jidc.16884', 'article-title': 'Intravenous high dose vitamin C and selected antiviral drugs in ' 'hospitalized COVID-19 patients: a descriptive cohort study', 'volume': '16', 'author': 'Fleifel', 'year': '2022', 'journal-title': 'J Infect Dev Ctries'}, { 'key': '2024111116104667700_nuae154-B46', 'doi-asserted-by': 'crossref', 'first-page': '638556', 'DOI': '10.3389/fphar.2021.638556', 'article-title': 'High dose intravenous vitamin C for preventing the disease aggravation ' 'of moderate COVID-19 pneumonia. A retrospective propensity matched ' 'before–after study', 'volume': '12', 'author': 'Zhao', 'year': '2021', 'journal-title': 'Front Pharmacol'}, { 'key': '2024111116104667700_nuae154-B47', 'first-page': '931', 'article-title': 'Clinical effect of the treatment of novel coronavirus pneumonia by ' 'internal administration of traditional Chinese medicine plus fumigation ' 'and absorption combined with super dose of vitamin C in treating ' 'COVID-19', 'volume': '41', 'author': 'Wang', 'year': '2020', 'journal-title': 'J Xi’an Jiaotong Univ (Medical Edition)'}, { 'key': '2024111116104667700_nuae154-B48', 'doi-asserted-by': 'crossref', 'first-page': '802', 'DOI': '10.1186/s13063-021-05795-4', 'article-title': 'The effect of supplementation with vitamins A, B, C, D, and E on ' 'disease severity and inflammatory responses in patients with COVID-19: ' 'a randomized clinical trial', 'volume': '22', 'author': 'Beigmohammadi', 'year': '2021', 'journal-title': 'Trials'}, { 'key': '2024111116104667700_nuae154-B49', 'first-page': '164', 'article-title': 'Efficacy of high dose vitamin C, melatonin and zinc in Iranian patients ' 'with acute respiratory syndrome due to coronavirus infection: a pilot ' 'randomized trial', 'volume': '6', 'author': 'Darban', 'year': '2020', 'journal-title': 'J Cell Molec Anesth'}, { 'key': '2024111116104667700_nuae154-B50', 'doi-asserted-by': 'crossref', 'first-page': '814587', 'DOI': '10.3389/fmed.2022.814587', 'article-title': 'Effect of vitamin C on clinical outcomes of critically ill patients ' 'with COVID-19: an observational study and subsequent meta-analysis', 'volume': '9', 'author': 'Gavrielatou', 'year': '2022', 'journal-title': 'Front Med (Lausanne)'}, { 'key': '2024111116104667700_nuae154-B51', 'doi-asserted-by': 'crossref', 'first-page': '717816', 'DOI': '10.3389/fimmu.2021.717816', 'article-title': 'The effect of vitamin C on pathological parameters and survival ' 'duration of critically ill coronavirus disease 2019 patients: a ' 'randomized clinical trial', 'volume': '12', 'author': 'Majidi', 'year': '2021', 'journal-title': 'Front Immunol'}, { 'key': '2024111116104667700_nuae154-B52', 'first-page': '5', 'article-title': 'Outcomes of high-dose vitamin C therapy on patients diagnosed with ' 'COVID-19 associated ARDS in intensive care units: multi-center ' 'retrospective study', 'volume': '14', 'author': 'Yuksel', 'year': '2023', 'journal-title': 'J Crit Intensive Care'}, { 'key': '2024111116104667700_nuae154-B53', 'doi-asserted-by': 'crossref', 'first-page': '102324', 'DOI': '10.1016/j.dsx.2021.102324', 'article-title': 'Vitamin C and COVID-19 treatment: a systematic review and meta-analysis ' 'of randomized controlled trials', 'volume': '15', 'author': 'Rawat', 'year': '2021', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '2024111116104667700_nuae154-B54', 'doi-asserted-by': 'crossref', 'first-page': '102797', 'DOI': '10.1016/j.ctim.2021.102797', 'article-title': 'The effectiveness of high-dose intravenous vitamin C for patients with ' 'coronavirus disease 2019: a systematic review and meta-analysis', 'volume': '64', 'author': 'Kwak', 'year': '2022', 'journal-title': 'Complement Ther Med'}, { 'key': '2024111116104667700_nuae154-B55', 'doi-asserted-by': 'crossref', 'first-page': '274', 'DOI': '10.1002/ncp.10832', 'article-title': 'Intravenous vitamin C use and risk of severity and mortality in ' 'COVID-19: a systematic review and meta-analysis', 'volume': '37', 'author': 'Ao', 'year': '2022', 'journal-title': 'Nutr Clin Pract'}, { 'key': '2024111116104667700_nuae154-B56', 'doi-asserted-by': 'crossref', 'first-page': 'e762', 'DOI': '10.1002/hsr2.762', 'article-title': 'Impact of high-dose vitamin C on the mortality, severity, and duration ' 'of hospital stay in COVID-19 patients: a meta-analysis', 'volume': '5', 'author': 'Bhowmik', 'year': '2022', 'journal-title': 'Health Sci Rep'}, { 'key': '2024111116104667700_nuae154-B57', 'doi-asserted-by': 'crossref', 'first-page': '3357', 'DOI': '10.1007/s10787-023-01200-5', 'article-title': 'The effect of vitamin C on the risk of mortality in patients with ' 'COVID-19: a systematic review and meta-analysis of randomized ' 'controlled trials', 'volume': '31', 'author': 'Kow', 'year': '2023', 'journal-title': 'Inflammopharmacology'}, { 'key': '2024111116104667700_nuae154-B58', 'doi-asserted-by': 'crossref', 'first-page': '1848', 'DOI': '10.3390/nu15081848', 'article-title': 'Association of oral or intravenous vitamin C supplementation with ' 'mortality: a systematic review and meta-analysis', 'volume': '15', 'author': 'Xu', 'year': '2023', 'journal-title': 'Nutrients'}, { 'key': '2024111116104667700_nuae154-B59', 'doi-asserted-by': 'crossref', 'first-page': '5346', 'DOI': '10.3390/molecules25225346', 'article-title': 'Mini-review on the roles of vitamin C, vitamin D, and selenium in the ' 'immune system against COVID-19', 'volume': '25', 'author': 'Bae', 'year': '2020', 'journal-title': 'Molecules'}, { 'key': '2024111116104667700_nuae154-B60', 'doi-asserted-by': 'crossref', 'first-page': '281', 'DOI': '10.3390/arm90040038', 'article-title': 'The role and efficacy of vitamin C in sepsis: a systematic review and ' 'meta-analysis', 'volume': '90', 'author': 'Muhammad', 'year': '2022', 'journal-title': 'Adv Respir Med'}, { 'key': '2024111116104667700_nuae154-B61', 'doi-asserted-by': 'crossref', 'first-page': '49', 'DOI': '10.1111/j.1365-2133.1980.tb05671.x', 'article-title': 'Neutrophil dysfunction and repeated infections: influence of levamisole ' 'and ascorbic acid', 'volume': '102', 'author': 'Rebora', 'year': '1980', 'journal-title': 'Br J Dermatol'}, { 'key': '2024111116104667700_nuae154-B62', 'doi-asserted-by': 'crossref', 'first-page': '119', 'DOI': '10.3109/08923978909082146', 'article-title': 'Monocyte locomotion in anergic chronic brucellosis patients: the in ' 'vivo effect of ascorbic acid', 'volume': '11', 'author': 'Boura', 'year': '1989', 'journal-title': 'Immunopharmacol Immunotoxicol'}], 'container-title': 'Nutrition Reviews', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://academic.oup.com/nutritionreviews/advance-article-pdf/doi/10.1093/nutrit/nuae154/60591063/nuae154.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'syndication'}, { 'URL': 'https://academic.oup.com/nutritionreviews/advance-article-pdf/doi/10.1093/nutrit/nuae154/60591063/nuae154.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 11, 11]], 'date-time': '2024-11-11T16:11:10Z', 'timestamp': 1731341470000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://academic.oup.com/nutritionreviews/advance-article/doi/10.1093/nutrit/nuae154/7889371'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 11, 11]]}, 'references-count': 62, 'URL': 'http://dx.doi.org/10.1093/nutrit/nuae154', 'relation': {}, 'ISSN': ['0029-6643', '1753-4887'], 'subject': [], 'published': {'date-parts': [[2024, 11, 11]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit